Literature DB >> 11496151

Auditory evoked magnetic fields in adults with fragile X syndrome.

D C Rojas1, T L Benkers, S J Rogers, P D Teale, M L Reite, R J Hagerman.   

Abstract

Hyper-reactivity and anxiety to sensory stimuli have been described in patients with fragile X syndrome (FXS), and may be related to abnormal processing in afferent sensory pathways. We used magnetoencephalography (MEG) to measure auditory responses to pure tones in 11 adults with FXS and 11 non-FXS subjects. The amplitude for the N100m auditory evoked field component was significantly higher for patients with FXS than for subjects. FXS subjects also had less lateralized N100m anterior-posterior dipole locations. These data may suggest that more neurons are activated by acoustic stimuli in FXS, consistent with subjective experience of increased stimulus intensity. Anomalous cerebral lateralization may suggest an early critical window for effects on neocortical development of the fragile X mental retardation protein (FMRP) produced by the FMR1 gene in individuals with FXS.

Entities:  

Mesh:

Year:  2001        PMID: 11496151     DOI: 10.1097/00001756-200108080-00056

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  26 in total

1.  The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.

Authors:  Jose Luis Olmos-Serrano; Joshua G Corbin; Mark P Burns
Journal:  Dev Neurosci       Date:  2011-11-08       Impact factor: 2.984

2.  Modulators of Kv3 Potassium Channels Rescue the Auditory Function of Fragile X Mice.

Authors:  Lynda El-Hassar; Lei Song; Winston J T Tan; Charles H Large; Giuseppe Alvaro; Joseph Santos-Sacchi; Leonard K Kaczmarek
Journal:  J Neurosci       Date:  2019-04-01       Impact factor: 6.167

3.  Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome.

Authors:  Jonathan W Lovelace; Maham Rais; Arnold R Palacios; Xinghao S Shuai; Steven Bishay; Otilia Popa; Patricia S Pirbhoy; Devin K Binder; David L Nelson; Iryna M Ethell; Khaleel A Razak
Journal:  Cereb Cortex       Date:  2020-03-14       Impact factor: 5.357

Review 4.  Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models.

Authors:  D Sinclair; B Oranje; K A Razak; S J Siegel; S Schmid
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

5.  Cardiovascular and behavioral response to auditory stimuli in boys with fragile X syndrome.

Authors:  Jane E Roberts; Anna C J Long; Lindsay M McCary; Amy N Quady; Bonnie S Rose; Dean Widrick; Grace Baranek
Journal:  J Pediatr Psychol       Date:  2012-11-11

6.  Local cortical circuit correlates of altered EEG in the mouse model of Fragile X syndrome.

Authors:  Sonal Goswami; Sheridan Cavalier; Vinay Sridhar; Kimberly M Huber; Jay R Gibson
Journal:  Neurobiol Dis       Date:  2019-01-09       Impact factor: 5.996

Review 7.  Fragile X: a family of disorders.

Authors:  Weerasak Chonchaiya; Andrea Schneider; Randi J Hagerman
Journal:  Adv Pediatr       Date:  2009

8.  Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome.

Authors:  Jay R Gibson; Aundrea F Bartley; Seth A Hays; Kimberly M Huber
Journal:  J Neurophysiol       Date:  2008-09-10       Impact factor: 2.714

9.  Aberrant functional organization and maturation in early-onset psychosis: evidence from magnetoencephalography.

Authors:  Tony W Wilson; Donald C Rojas; Peter D Teale; Olivia O Hernandez; Ryan M Asherin; Martin L Reite
Journal:  Psychiatry Res       Date:  2007-08-28       Impact factor: 3.222

10.  The neural basis of auditory temporal discrimination in girls with fragile X syndrome.

Authors:  Scott S Hall; Elizabeth Walter; Elena Sherman; Fumiko Hoeft; Allan L Reiss
Journal:  J Neurodev Disord       Date:  2009-03       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.